药学学报, 2021, 56(11): 2916-2922
引用本文:
陈浩, 李小枫, 王华. 铁死亡调控肝纤维化中的作用机制研究进展[J]. 药学学报, 2021, 56(11): 2916-2922.
CHEN Hao, LI Xiao-feng, WANG Hua. Research progress on the mechanism of ferroptosis in regulating liver fibrosis[J]. Acta Pharmaceutica Sinica, 2021, 56(11): 2916-2922.

铁死亡调控肝纤维化中的作用机制研究进展
陈浩1,2, 李小枫3,4, 王华5*
1. 安徽医科大学第一附属医院药剂科, 安徽 合肥 230022;
2. 国家中医药管理局中药化学三级实验室, 安徽 合肥 230022;
3. 安徽医科大学药学院, 安徽 合肥 230032;
4. 安徽医科大学炎症免疫性疾病安徽省实验室, 安徽 合肥 230032;
5. 安徽医科大学第一附属医院肿瘤内科, 安徽 合肥 230022
摘要:
肝纤维化是多种慢性肝病发展为肝硬化和肝癌所必须经历的共同病理过程。肝纤维化在发生、发展过程中受到多种细胞因子以及信号通路的调控。近年来,大量研究表明铁死亡 (ferroptosis) 与肝纤维化密切相关,与正常肝脏相比,发生纤维化的肝脏内铁离子水平和脂质过氧化程度显著增加。因此,铁死亡可能是肝纤维化疾病诊断、预防和治疗的潜在靶标。本文就近年来关于铁死亡在肝纤维化中的作用进行综述,以期为肝纤维化的治疗提供新的思路。
关键词:    铁死亡      肝星状细胞      肝纤维化      铁离子      脂质过氧化     
Research progress on the mechanism of ferroptosis in regulating liver fibrosis
CHEN Hao1,2, LI Xiao-feng3,4, WANG Hua5*
1. Department of Pharmacy, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, China;
2. The Grade 3 Pharmaceutical Chemistry Laboratory of State Administration of Traditional Chinese Medicine, Hefei 230022, China;
3. School of Pharmacy, Anhui Medical University, Hefei 230032, China;
4. Inflammation and Immune Mediated Disease Laboratory of Anhui Province, Anhui Medical University, Hefei 230032, China;
5. Department of Oncology, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, China
Abstract:
Liver fibrosis is a common pathological process that many chronic liver diseases must undergo to develop into cirrhosis and hepatocellular carcinoma. Liver fibrosis is regulated by a variety of cytokines and signal pathways during its occurrence and development. In recent years, a large number of studies showed that ferroptosis is closely related to liver fibrosis. Compared with normal liver, the levels of irons and lipid peroxidation in the liver with fibrosis are significantly increased. Therefore, ferroptosis may be a potential target for the diagnosis, prevention, and treatment of liver fibrosis. This review summarizes the role of ferroptosis in liver fibrosis, thus to provide new ideas for the treatment of liver fibrosis.
Key words:    ferroptosis    hepatic stellate cell    liver fibrosis    iron    lipid peroxidation   
收稿日期: 2021-06-28
DOI: 10.16438/j.0513-4870.2021-0959
基金项目: 国家自然科学基金资助项目(81770588).
通讯作者: 王华,Tel:86-551-65161056,E-mail:wanghua@ahmu.edu.cn
Email: wanghua@ahmu.edu.cn
相关功能
PDF(1011KB) Free
打印本文
0
作者相关文章
陈浩  在本刊中的所有文章
李小枫  在本刊中的所有文章
王华  在本刊中的所有文章

参考文献:
[1] Cohen-Naftaly M, Friedman SL. Current status of novel antifibrotic therapies in patients with chronic liver disease[J]. Therap Adv Gastroenterol, 2011, 4: 391-417.
[2] Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis[J]. Annu Rev Pathol, 2011, 6: 425-456.
[3] Tacke F, Trautwein C. Mechanisms of liver fibrosis resolution[J]. J Hepatol, 2015, 63: 1038-1039.
[4] Cortes E, Lachowski D, Rice A, et al. Retinoic acid receptor beta is downregulated in hepatocellular carcinoma and cirrhosis and its expression inhibits myosin driven activation and durotaxis in hepatic stellate cells[J]. Hepatology, 2019, 69: 785-802.
[5] Anderson ER, Shah YM. Iron homeostasis in the liver[J]. Compr Physiol, 2013, 3: 315-330.
[6] Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death[J]. Cell, 2012, 149: 1060-1072.
[7] Stockwell BR, Friedmann Angeli JP, Bayir H, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox, biology, and disease[J]. Cell, 2017, 171: 273-285.
[8] Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease[J]. Nat Rev Mol Cell Biol, 2021, 22: 266-282.
[9] Viswanathan VS, Ryan MJ, Dhruv HD, et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway[J]. Nature, 2017, 547: 453-457.
[10] Hangauer MJ, Viswanathan VS, Ryan MJ, et al. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition[J]. Nature, 2017, 551: 247-250.
[11] Tsoi J, Robert L, Paraiso K, et al. Multi-stage differentiation defines melanoma subtypes with differential vulnerability to drug-induced iron-dependent oxidative stress[J]. Cancer Cell, 2018, 33: 890-904.
[12] Yang WS, Stockwell BR. Ferroptosis: death by lipid peroxidation[J]. Trends Cell Biol, 2016, 26: 165-176.
[13] Cao JY, Dixon SJ. Mechanisms of ferroptosis[J]. Cell Mol Life Sci, 2016, 73: 2195-2209.
[14] Yang WS, SriRamaratnam R, Welsch ME, et al. Regulation of ferroptotic cancer cell death by GPX4[J]. Cell, 2014, 156: 317-331.
[15] Yu HT, Guo PG, Xie XZ, et al. Ferroptosis, a new form of cell death, and its relationships with tumourous diseases[J]. J Cell Mol Med, 2017, 21: 648-657.
[16] Andrews NC, Schmidt PJ. Iron homeostasis[J]. Annu Rev Physiol, 2007, 69: 69-85.
[17] Verbon EH, Trapet PL, Stringlis IA, et al. Iron and immunity[J]. Annu Rev Phytopathol, 2017, 55: 355-375.
[18] Hentze MW, Muckenthaler MU, Galy B, et al. Two to tango: regulation of mammalian iron metabolism[J]. Cell, 2010, 142: 24-38.
[19] Yang WS, Stockwell BR. Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells[J]. Chem Biol, 2008, 15: 234-245.
[20] Hou W, Xie Y, Song X, et al. Autophagy promotes ferroptosis by degradation of ferritin[J]. Autophagy, 2016, 12: 1425-1428.
[21] Bogdan AR, Miyazawa M, Hashimoto K, et al. Regulators of iron homeostasis: new players in metabolism, cell death, and disease[J]. Trends Biochem Sci, 2016, 41: 274-286.
[22] Chang LC, Chiang SK, Chen SE, et al. Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis[J]. Cancer Lett, 2018, 416: 124-137.
[23] Hassannia B, Vandenabeele P, Vanden Berghe T. Targeting ferroptosis to iron out cancer[J]. Cancer Cell, 2019, 35: 830-849.
[24] Suttner DM, Dennery PA. Reversal of HO-1 related cytoprotection with increased expression is due to reactive iron[J]. FASEB J, 1999, 13: 1800-1809.
[25] Sui M, Jiang X, Chen J, et al. Magnesium isoglycyrrhizinate ameliorates liver fibrosis and hepatic stellate cell activation by regulating ferroptosis signaling pathway[J]. Biomed Pharmacother, 2018, 106: 125-133.
[26] Zhang Z, Yao Z, Wang L, et al. Activation of ferritinophagy is required for the RNA-binding protein ELAVL1/HuR to regulate ferroptosis in hepatic stellate cells[J]. Autophagy, 2018, 14: 2083-2103.
[27] Zhang Z, Guo M, Li Y, et al. RNA-binding protein ZFP36/TTP protects against ferroptosis by regulating autophagy signaling pathway in hepatic stellate cells[J]. Autophagy, 2020, 16: 1482-1505.
[28] Zhang Z, Guo M, Shen M, et al. The BRD7-P53-SLC25A28 axis regulates ferroptosis in hepatic stellate cells[J]. Redox Biol, 2020, 36: 101619.
[29] Yu Y, Jiang L, Wang H, et al. Hepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis[J]. Blood, 2020, 136: 726-739.
[30] Wang L, Zhang Z, Li M, et al. P53-dependent induction of ferroptosis is required for artemether to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation[J]. IUBMB Life, 2019, 71: 45-56.
[31] Li Y, Jin C, Shen M, et al. Iron regulatory protein 2 is required for artemether-mediated anti-hepatic fibrosis through ferroptosis pathway[J]. Free Radic Biol Med, 2020, 160: 845-859.
[32] Kong Z, Liu R, Cheng Y. Artesunate alleviates liver fibrosis by regulating ferroptosis signaling pathway[J]. Biomed Pharmacother, 2019, 109: 2043-2053.
[33] Kuo CY, Chiu V, Hsieh PC, et al. Chrysophanol attenuates hepatitis B virus X protein-induced hepatic stellate cell fibrosis by regulating endoplasmic reticulum stress and ferroptosis[J]. J Pharmacol Sci, 2020, 144: 172-182.
[34] Xu WH, Li CH, Jiang TL. Ferroptosis pathway andits intervention regulated by Chinese materia medica[J]. China J Chin Mater Med (中国中药杂志), 2018, 43: 4019-4026.
[35] Lin Y, Yang CQ, Lian WY, et al. Ophiopogonin D interferes with ferroptosis to reduce the damage of cardiomyocytes induced by ophiopogonin D'[J]. Acta Pharm Sin (药学学报), 2021, 56: 2241-2247.
[36] Sun X, Ou Z, Chen R, et al. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells[J]. Hepatology, 2016, 63: 173-184.
[37] Sun X, Niu X, Chen R, et al. Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis[J]. Hepatology, 2016, 64: 488-500.
[38] Jiang L, Kon N, Li T, et al. Ferroptosis as a p53-mediated activity during tumour suppression[J]. Nature, 2015, 520: 57-62.
[39] Qu Y, Wang SJ, Li D, et al. Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses[J]. Proc Natl Acad Sci U S A, 2016, 113: E6806-E6812.
[40] Xie YC, Zhu S, Song XX, et al. The tumor suppressor p53 limits ferroptosis by blocking DPP4 activity[J]. Cell Rep, 2017, 20: 1692-1704.
[41] Louandre C, Marcq I, Bouhlal H, et al. The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells[J]. Cancer Lett, 2015, 356: 971-977.
[42] Lei G, Mao C, Yan Y, et al. Ferroptosis, radiotherapy, and combination therapeutic strategies[J]. Protein Cell, 2021. DOI: 10.1007/s13238-021-00841-y.
[43] Sleire L, Skeie BS, Netland IA, et al. Drug repurposing: sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc-, leading to glutathione depletion[J]. Oncogene, 2015, 34: 5951-5959.
[44] Ooko E, Saeed ME, Kadioglu O, et al. Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells[J]. Phytomedicine, 2015, 22: 1045-1054.
[45] Nishizawa S, Araki H, Ishikawa Y, et al. Low tumor glutathione level as a sensitivity marker for glutamate-cysteine ligase inhibitors[J]. Oncol Lett, 2018, 15: 8735-8743.
[46] Guo J, Xu B, Han Q, et al. Ferroptosis: a novel anti tumor action for cisplatin[J]. Cancer Res Treat, 2018, 50: 445-460.
[47] Kose T, Vera-Aviles M, Sharp PA, et al. Cuecumin and (-)-epigallocatechin 3 gallate protect murine min6 pancreatic beta cells against iron toxicity and erastin induced ferroptosis[J]. Pharmaceuticals, 2019, 12: 26.
[48] Xie Y, Song X, Sun X, et al. Identification of baicalein as a ferroptosis inhibitor by natural product library screening[J]. Biochen Biophys Res Commun, 2016, 473: 775-780.
[49] Kim KM, Cho SS, Ki SH. Emerging roles of ferroptosis in liver pathophysiology[J]. Arch Pharm Res, 2020, 43: 985-996.
[50] Doll S, Proneth B, Tyurina YY, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition[J]. Nat Chem Biol, 2017, 13: 91-98.
[51] Abrams RP, Carroll WL, Woerpel KA. Five-membered ring peroxide selectively initiatesferroptosis in cancer cells[J]. ACS Chem Biol, 2016, 11: 1305-1312.
[52] Guerrero-Hue M, Garcia-Caballero C, Palomino-Antolin A, et al. Curcumin reduces renal damage associated with rhabdomyolysis by decreasing ferroptosis-mediated cell death[J]. FASEB J, 2019, 33: 8961-8975.
[53] Chu J, Liu CX, Song R, et al. Ferrostatin-1 protects HT-22 cells from oxidative toxicity[J]. Neural Regen Res, 2020, 15: 528-536.
[54] Li CQ, Tang HX, Zhang Y, et al. Construction and anti-tumor research progress of ferroptosis-inducing nanomedicine[J]. Acta Pharm Sin (药学学报), 2020, 55: 2099-2109.
[55] Nairz M, Schleicher U, Schroll A, et al. Nitric oxide-mediated regulation of ferroportin-1 controls macrophage iron homeostasis and immune function in Salmonella infection[J]. J Exp Med, 2013, 210: 855-873.
[56] Wang Z, Yin W, Zhu L, et al. Iron drives T helper cell pathogenicity by promoting RNA binding protein PCBP1 mediated proinflammatory cytokine production[J]. Immunity, 2018, 49: 80-92.
[57] Proneth B, Conrad M. Ferroptosis and necroinflammation, a yet poorly explored link[J]. Cell Death Differ, 2019, 26: 14-24.
[58] Kraft VAN, Bezjian CT, Pfeiffer S, et al. GTP cyclohydrolase 1/tetrahydrobiopterin counteract ferroptosis through lipid remodeling[J]. ACS Cent Sci, 2020, 6: 41-53.
[59] Feng HZ, Schorpp K, Jin J, et al. Transferrin receptor is a specific ferroptosis marker[J]. Cell Rep, 2020, 30: 3411-3423.e7.
相关文献:
1.杨挺, 陈馨霖, 祝小云, 项德娟, 罗建光*, 张浩*.苦蘵睡茄内酯提取物下调YAP和TGF-β/Smad通路抑制肝星状细胞激活改善小鼠肝纤维化[J]. 药学学报, 2021,56(11): 2985-2994
2.赵喆, 鲍秀琦, 张丹.铁死亡调控机制及其在帕金森病中的研究进展[J]. 药学学报, 2019,54(3): 399-406
3.张文东, 王瑞范, 吴会敏, 杨慧, 王国成.抗肝纤维化药物研发进展[J]. 药学学报, 2018,53(5): 667-675
4.黄晓平, 王晓, 谢晓兰, 徐文涛, 杨会勇, 李招发, 林俊生, 刁勇.Kallistatin通过Akt-eNOS信号通路对肝星状细胞氧化损伤的保护作用[J]. 药学学报, 2017,52(9): 1397-1403
5.赵双双, 邵荣光, 何红伟.抗肝纤维化的潜在作用靶点[J]. 药学学报, 2014,49(10): 1365-1371
6.平 洁 高爱梅 徐 丹 李瑞雯 汪 晖.吲哚-3-原醇对猪血清诱导大鼠肝纤维化的治疗作用[J]. 药学学报, 2011,46(8): 915-921
7.吴俊燏;刘耕陶.Kupffer细胞在肝纤维化形成与转归中的作用[J]. 药学学报, 2008,43(9): 884-889